Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients

NCT01025817 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

613

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: Everolimus and tacrolimus
DRUG: mycophenolate mofetil and tacrolimus

Sponsor

Novartis Pharmaceuticals